(Q53960282)

23 May 2018

title

Psoriasis: response to high-dose intravenous immunoglobulin in three patients. (English)

1 reference

23 May 2018

author name string

Gurmin V

1

1 reference

23 May 2018

Mediwake R

2

1 reference

23 May 2018

Fernando M

3

1 reference

23 May 2018

Whittaker S

4

1 reference

23 May 2018

Rustin MH

5

1 reference

23 May 2018

Beynon HL

6

1 reference

23 May 2018

language of work or name

English

0 references

publication date

1 September 2002

1 reference

23 May 2018

British Journal of Dermatology

published in

1 reference

23 May 2018

volume

147

1 reference

23 May 2018

issue

3

1 reference

23 May 2018

page(s)

554-557

1 reference

23 May 2018

cites work

Treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.04753.X

Epidemiology of psoriasis: clinical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.04753.X

The treatment of atopic dermatitis with adjunctive high-dose intravenous immunoglobulin: a report of three patients and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.04753.X

Intracellular interleukin-4 profiles during high-dose intravenous immunoglobulin treatment of therapy-resistant atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.04753.X

A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.04753.X

Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: An open study with 20 adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.04753.X

Dermatological uses of high-dose intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.04753.X

The skin immune system: progress in cutaneous biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.04753.X

Keratinocytes as initiators of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.04753.X

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.04753.X

Recent developments in the understanding of the pathogenesis of psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.04753.X

Immunomodulating effects of intravenous immunoglobulin in autoimmune and inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.04753.X

Adverse effects of intravenous immunoglobulin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.04753.X

Requirements for safety and quality of intravenous immunoglobulin G preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.04753.X

10.1046/J.1365-2133.2002.04753.X

21 January 2018

Identifiers

DOI

1 reference

23 May 2018

1 reference

23 May 2018